4-iodoclonidine has been researched along with Hypertension in 1 studies
4-iodoclonidine: structure given in first source
Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Moxonidine is a centrally acting antihypertensive with a selective action on I1-imidazoline receptors in RVLM." | 1.29 | Selective antihypertensive action of moxonidine is mediated mainly by I1-imidazoline receptors in the rostral ventrolateral medulla. ( Dreshaj, I; Ernsberger, P; Haxhiu, MA; Schäfer, SG, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haxhiu, MA | 1 |
| Dreshaj, I | 1 |
| Schäfer, SG | 1 |
| Ernsberger, P | 1 |
1 other study available for 4-iodoclonidine and Hypertension
| Article | Year |
|---|---|
Selective antihypertensive action of moxonidine is mediated mainly by I1-imidazoline receptors in the rostral ventrolateral medulla.
Topics: Adrenergic alpha-Antagonists; Affinity Labels; Animals; Antihypertensive Agents; Benzazepines; Benzo | 1994 |